The Library
HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production
Tools
Obregon, Patricia, Chargelegue, Daniel, Drake, Pascal M.W., Prada, Alessandra, Nuttall, James, Frigerio, Lorenzo and Ma, Julian K.-C. (2006) HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnology Journal, Vol.4 (No.2). pp. 195-207. doi:10.1111/j.1467-7652.2005.00171.x ISSN 1467-7644.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1111/j.1467-7652.2005.00171.x
Abstract
We describe the engineering of a human immunodeficiency virus-1 (HIV-1) p24-immunoglobulin A (IgA) antigen-antibody fusion molecule for therapeutic purposes and its enhancing effect on fused antigen expression in tobacco plants. Although many recombinant proteins have been expressed in transgenic plants as vaccine candidates, low levels of expression are a recurring problem. In this paper, using the HIV p24 core antigen as a model vaccine target, we describe a strategy for increasing the yield of a recombinant protein in plants. HIV p24 antigen was expressed as a genetic fusion with the alpha 2 and alpha 3 constant region sequences from human Ig alpha-chain and targeted to the endomembrane system. The expression of this fusion protein was detected at levels approximately 13-fold higher than HIV p24 expressed alone, and a difference in the behaviour of the two recombinant proteins during trafficking in the plant secretory pathway has been identified. Expressing the antigen within the context of alpha-chain 1g sequences resulted in the formation of homodimers and the antigen was correctly recognized by specific antibodies. Furthermore, the HIV p24 elicited T-cell and antibody responses in immunized mice. The use of Ig fusion partners is proposed as a generic platform technology for up-regulating the expression of antigens in plants, and may represent the first step in a strategy to design new vaccines with enhanced immunological properties.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Subjects: | T Technology > TP Chemical technology S Agriculture > SB Plant culture |
||||
Divisions: | Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) > Biological Sciences ( -2010) Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) |
||||
Journal or Publication Title: | Plant Biotechnology Journal | ||||
Publisher: | Wiley-Blackwell Publishing Ltd. | ||||
ISSN: | 1467-7644 | ||||
Official Date: | March 2006 | ||||
Dates: |
|
||||
Volume: | Vol.4 | ||||
Number: | No.2 | ||||
Number of Pages: | 13 | ||||
Page Range: | pp. 195-207 | ||||
DOI: | 10.1111/j.1467-7652.2005.00171.x | ||||
Status: | Not Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Open Access (Creative Commons) | ||||
Funder: | European Community Marie Curie Fellowship | ||||
Grant number: | ERBFMBICT983528 |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |